Get started
Author

Hannah Calkins

OpenAlex ID: A5002484468
A nanotherapeutic strategy to target drug‐tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
2023 · Tatiana Shaurova, Lingyue Yan, et al. · 癌症：英文版 · 7
PDF
Abstract 1093: BRD9 inhibition overcomes epithelial to mesenchymal transition (EMT)-associated tyrosine kinase inhibitor (TKI) tolerance in epidermal growth factor receptor (EGFR) mutant lung cancer
2022 · Hannah Calkins, Tatiana Shaurova, et al. · Cancer Research · 2
Circulating tumor DNA in locally advanced cervical cancer: A real-world cohort study
2026 · Theresa Kuhn, A. Gabriella Wernicke, et al. · Gynecologic Oncology
Utilization of tumor-informed ctDNA to de-escalate treatment or monitoring in metastatic breast cancer exceptional responders.
2025 · Guneet Singh Janda, Matthew P. Goetz, et al. · Journal of Clinical Oncology
PDF
Vitamin D in the management of lung cancer
2023 · Tatiana Shaurova, Hannah Calkins, et al. · Elsevier eBooks
List of contributors
2023 · John S. Adams, Karin Amrein, et al. · Elsevier eBooks
List of contributors
2023 · John S. Adams, Karin Amrein, et al. · Elsevier eBooks
Works count: 8
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type